FDA Investigator Howard A Burmester

Howard A Burmester has inspections in 6 countries as of 27 Oct 2023. Howard A Burmester has collaborated with a combinined 3492 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
1410
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100004839
Country:
United States of America, Brazil, Grenada, Canada, Guyana
Co-Investigator(s):
A Williams, Aaron L Dunbar, Aimee J Edwin, Alecia L Marson, Alfred P Pistorio, Alison A Nicoli, Amos, Amy L Mcintyre, Ana M Placencia, Anthony J Ladner, Anthony P Duran, April L Young, Baask, Benedict, Benjamin W Anderson, Billi Jom Johnson, Boun M Xiong, Bradley A Servais, Brian E Thompson, Brian L Szcyubialka, Bunce, Carolyn A Warren, Catherine M Vanderhoef, Chad W Rice, Charles R Cote, RIC, Christina A Castineyra, Clifford F Long, Como, Constance Lrichard Math, Corey K Reno, Courtney R Ingalsbe, Courtney R Tiegs, Dacia E Quick, Dale A Nyberg, Dareus J Montreal, Darlene L Krieger, Darrell E Luedtke, Darren D Holaday, David J Leray, David J Ward, Demetria L Lueneburg, Denise L Burosh, Diane T Reindl, Dianna C Sonnenburg, Douglas J Snyder, Duc Minh H Nguyen, Edward A Fabiano, Elizabeth E Hart (ASCP), MT, Elizabeth P Mayer, Ellen C Weisensel, Emily E Markgraf, English, Eric A Breselow, Eric T Huebler, Fannie M Harrell, Frank S Sedzielarz, Frederick J Tillman, Garrett W Steiner, Gina M Scholze, Grant M Ruis, Gregory A Ryberg, Gregory S Larson, Gregory W Smith, Harperd, Heather Akleimola Hulbert, Henry E Sanchez, Hustedtj, Ismael Olvera, IV, Ivan E Reyes, J Benedict, Jacob W Reynolds, Jake T Lane, James I Jahr, James K Ireland, Jamie R Thompson, Jane E Nelson, Janis R Armedoriz, Jasjeet K Sekhon, Jean M Bosenbecker, Jean M Trimbo, Jennifer Alongie Vollom, Jennifer Guttuso, Jennifer R Mathern, Jeremy L Tri, Jesse P Romenesko, Jessica L Barr, Jessica M Novak, Joel D Hustedt, John A Iwen, John E Emmert, John P Hermann, Jon C Polzine, Jonathan G Gayechuway, Jonathan L Blonk, Joseph J Golden, Joseph M Edwin, Julie Woodberry, Justin A Boyd, Karen M Labounty, Karla J Youngberg, Katherine A Clarke Girolamo, Kathryn M Mogen, Kazar, Kellie L Thommes, RN, Kellie L Westerbuhr, Kenneth A Libertoski, Kevin L Torgerson, Kia L Copeland, Kibily D Dembele, Kimberly Lewandowski Walker, Kimberly W Destromp, Krista K Petersen, Kristy E Zuroski, Kuehbornl, Kyle J Mccracken, Larae M Koopman, Lauren E Merz, Lauren E Sanger, Leonardm, Lewis K Antwi, Liliya V Bubiy, Lillian C Hsu, Linda K Cline, Linda V Weyer, Lisa L Flores, Lisa M Lopez, Lourdes Andujar, Mada A Tautges, Maere A Fadden, Margaret L Bolte, Margaret M Lubbers Solberg, Maria E Treadwell, Marie A Fadden, Marissa S Steinhagen, Mary Ann Ruff, Melanie C Voges, Melissa D Kalik, Melissa I Michurski, Melissa J Holz, Miles D Foster, Mohammed H Adam, Msdap Gonzlezk, Nicholas S Vasilakes, Nicole C Shokatz, Nicole C Victoria, PhD, Paola E Lathrop, Patricia A Holmstrom, Patrick E Gainer, Patrick J Campbell, Peter T Erlandson, Ralph Jerndal, Rebecca L Caulfield, Rebecca L Keller, Rebecca L Mullikin, Richard W Koller, Robert H Claflin, Robert J Waldorf, Ronald R Ruff, Ross J Grigsby, Rostislav Servetnyk, Sana A Elassar, Sandra A Hughes, Sandra Sejdinovic, Sarah A Palmer, Scott A Golladay, Scott B Laufenberg, Scott L Schenian, Seth A Abbott, Shalonda C Clifford, Sharon K Thoma, PharmD, Sharon L Matson, Sharon M Harold, Shaun M Olson, State Agency, Steven A Skaar, Susan M Miller, Susan M North, Suzanne M Crotty, Tanya L Keigley, Tara C Singh, Tara M Carolfi, Tara M Humfeld, Tenzin Jangchup, Terrance L Scheiber, Theresa C Klaman, Thomas J Arista, Thomas S Donaldson, Timothy R Marrs, Tony T Yang, Traci C Kelm, Troy A Brenny, Tyson J Eldridge Stedman, Victoria L Palmer, Wayne W Grundstrom, Wendy L Trefethren Grang, William E Keer, William E Kefr, William F Lagud, Jr, Yehualashet A Gessesse, Zachary P Wachlarowicz

Howard A Burmester's Documents

Publish Date Document Type Title
July, 2015 FDA 483 Steuart Laboratories - Form 483, 2015-07-10
September, 2002 EIR Dakota Lions Sight & Health - EIR, 2002-09-11
February, 2002 FDA 483 South Dakota Lions Eye Bank - Form 483, 2002-02-28
April, 2001 EIR Sanford Medical Center (Blood Bank) - EIR, 2001-04-06
October, 2010 FDA 483 Steuart Laboratories - Form 483, 2010-10-01
September, 2002 FDA 483 Dakota Lions Sight & Health - Form 483, 2002-09-11
February, 2006 FDA 483 Steuart Laboratories - Form 483, 2006-02-27
August, 2003 EIR 3M Company - EIR, 2003-08-22
October, 2003 EIR Sanford Medical Center (Blood Bank) - EIR, 2003-10-02
February, 2003 FDA 483 Dr. Wilson T. Asfora, MD, FRCSC, PC - Form 483, 2003-02-28
March, 2000 EIR Matheson Tri-Gas, Inc. - EIR, 2000-03-22
August, 2018 FDA 483 Associated Milk Producers Inc. - Form 483, 2018-08-10
August, 2002 EIR South Dakota Lion's Eye Bank - EIR, 2002-10-07
April, 2003 FDA 483 Fuller, William, MD, Clinical Investigator - Form 483, 2003-04-10
January, 2013 EIR Kronebusch Farms, Inc. - EIR, 2013-01-16
June, 2014 FDA 483 Response Brian E. Driver, MD, Sponsor/Investigator - Form 483R, 2014-07-14
September, 2012 FDA 483 Steuart Laboratories - Form 483, 2012-09-10
April, 2003 EIR Fuller, William, MD, Clinical Investigator - EIR, 2003-04-09
June, 2014 FDA 483 Brian E. Driver, MD, Sponsor/Investigator - Form 483, 2014-06-26
January, 2016 FDA 483 Zurex PharmAgra, LLC - Form 483, 2016-01-08
February, 2002 EIR South Dakota Lions Eye Bank - EIR, 2002-02-28
June, 2014 EIR Brian E. Driver, MD, Sponsor/Investigator - EIR, 2014-06-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more